Table S9 from Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti–PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast Cancer

Key Points

Activation defects in Vg9Vd2 T cells were restored by anti-BTN3A therapy, enhancing their antitumor efficacy.
Pseudotime analysis indicated a distinct antitumor profile in Vg9Vd2 T cells linked with anti-PD-(L)1 responses.
Approach involved assessing Vg9Vd2 T cell function in relation to activation and cancer response mechanisms.
Findings may suggest new therapeutic strategies for improving immune response in triple-negative breast cancer.

We only have this paper's title and publication details.

Pseudotime analysis reveals Vg9Vd2 T cell activation defects, highlighting potential of anti-BTN3A therapy.

Pseudotime analysis of Vg9Vd2 T cells outputs, related to Figure 3

No takes yet. Share an insight, caveat, or question.

Fattori et al. (2025) studied this question.

View at Publisher

Ask AI

Bookmark

Share